The current valuation score of Fennec Pharmaceuticals Inc is 9.30, ranking 29 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -36.55, which is -404.58% below the recent high of 111.31 and -1102.79% above the recent low of -439.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.